Here, we investigated the effect of Roflumilast, a PDE4 inhibitor increasing cAMP levels, on a panel of irradiation-induced endothelial dysfunctions in human pulmonary microvascular endothelial cells (HPMECs). Here, PDE4A is linked to endothelial dysfunction.